We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VBBR3:BMFBOVESPAVibra Energia SA Analysis

Data as of 2026-05-28 - not real-time

R$31.02

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Vibra Energia trades at BRL 31.02, well below its DCF‑derived fair value of BRL 51.93, implying roughly 16 % upside. The stock sits just above the identified support of BRL 30.82 and below the 20‑day SMA of BRL 32.86, while the 200‑day SMA of BRL 26.72 confirms a long‑term bullish backdrop. Technical momentum is mixed: the MACD histogram is negative and the signal line is bearish, RSI at 37 suggests modest oversold pressure, and volume trends are decreasing.
Fundamentally, the company posted a 7 % revenue growth and a 109 % YoY jump in adjusted EBITDA in Q1 2026, supporting a robust cash‑flow profile (free cash flow BRL 4.56 bn) and a sustainable dividend yield of 5.99 % with a 60 % payout ratio. Valuation multiples (PE 12×, PB 1.8×) are attractive relative to peers, and the beta of ~0.65 indicates lower market sensitivity, though 30‑day volatility of 27 % signals price swings. Combined with a solid dividend and a clear growth narrative in renewable and B2B segments, the stock appears undervalued and positioned for medium‑ to long‑term appreciation.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near support but below short‑term SMA
  • Bearish MACD and decreasing volume
  • Neutral RSI indicating limited upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF upside of ~16 % and attractive valuation multiples
  • Strong Q1 EBITDA growth and solid cash flow
  • High dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Long‑term undervaluation relative to fair value
  • Diversification into renewable and B2B segments
  • Consistent dividend and low beta indicating defensive profile

Key Metrics & Analysis

Financial Health

Revenue Growth7.00%
Profit Margin1.56%
P/E Ratio12.1
ROE13.96%
ROA6.69%
Debt/Equity109.87
P/B Ratio1.8
Op. Cash FlowR$8.4B
Free Cash FlowR$4.6B

Technical Analysis

TrendBullish
RSI37.3
SupportR$30.82
ResistanceR$34.07
MA 20R$32.86
MA 50R$32.32
MA 200R$26.72
MACDBearish
VolumeDecreasing
Fear & Greed Index91.8

Valuation

Fair ValueR$51.93
Target PriceR$36.11
Upside/Downside16.40%
GradeUndervalued
TypeBlend
Dividend Yield5.99%

Risk Assessment

Beta0.65
Volatility27.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.